UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pancreaticojejunostomy Stricture After Pancreatoduodenectomy: Outcomes After Operative Revision

Journal of gastrointestinal surgery, 2016-02, Vol.20 (2), p.293-299

2016

Volltextzugriff (PDF)

A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma

HPB (Oxford, England), 2016-04, Vol.18 (4), p.305-311

2016

Volltextzugriff (PDF)

Analysis of the Cost Effectiveness of Laparoscopic Pancreatoduodenectomy

Journal of gastrointestinal surgery, 2017-09, Vol.21 (9), p.1404-1410

2017

Volltextzugriff (PDF)

Intraductal papillary mucinous neoplasm of the pancreas, one manifestation of a more systemic disease?

The American journal of surgery, 2016-03, Vol.211 (3), p.512-518

2016

Volltextzugriff (PDF)

Invasive, mixed-type intraductal papillary mucinous neoplasm: Superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm

Surgery, 2015-10, Vol.158 (4), p.937-945

2015

Volltextzugriff (PDF)

Local blockade of integrins in the temporomandibular joint region reduces Fos-positive neurons in trigeminal subnucleus caudalis of female rats produced by jaw movement

Pain (Amsterdam), 2006-11, Vol.125 (1), p.65-73

2006

Volltextzugriff (PDF)

Biliary intervention rates during neoadjuvant therapy for adenocarcinoma of the pancreatic head

HPB (Oxford, England), 2021-08, Vol.23 (8), p.1196-1200

2021

Volltextzugriff (PDF)

Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma

Journal of gastrointestinal surgery, 2016-03, Vol.20 (3), p.479-487

2016

Volltextzugriff (PDF)

A phase II, open-label pilot study evaluating the safety and activity of Nal-IRI in combination with 5-FU and oxaliplatin in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI Study) (NCT03483038)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.TPS790-TPS790

2020

Volltextzugriff (PDF)

Su1403 Surgical Transgastric Necrosectomy for Symptomatic Pancreatic Necrosis in Acute Necrotizing Pancreatitis

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S1213-S1214

2016

Volltextzugriff (PDF)

412 - A Soluble Protein Signature can Predict Post-Surgical Survival in Pancreatic Adenocarcinoma

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-1266-S-1266

2018

Volltextzugriff (PDF)

Hepatic angiosarcoma five years following spontaneous intraperitoneal bleed of a hepatic mass

Rare tumors, 2009-12, Vol.1 (2), p.e33-101

2009

Volltextzugriff (PDF)

A phase II, open-label pilot study evaluating the safety and activity of nal-IRI in combination with 5-FU and oxaliplatin in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI study)

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.TPS476-TPS476

2019

Volltextzugriff (PDF)

Final toxicity results from a phase II study of 5-fluorouracil, oxaliplatin, and dasatinib (FOLFOX-D) in previously untreated metastatic pancreatic adenocarcinoma

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.504-504

2018

Volltextzugriff (PDF)

Characteristics of circulating tumor cells in newly diagnosed metastatic pancreatic adenocarcinoma

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.304-304

2018

Volltextzugriff (PDF)

Circulating tumor cells as a surrogate for treatment response in patients with metastatic pancreatic adenocarcinoma

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.318-318

2018

Volltextzugriff (PDF)

Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes

Journal of gastrointestinal surgery, 2020, Vol.24 (1), p.76-87

2020

Volltextzugriff (PDF)

Final results from a phase II study of 5-fluorouracil, oxaliplatin, and dasatinib (FOLFOX-D) in previously untreated metastatic pancreatic adenocarcinoma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.4124-4124

2018

Volltextzugriff (PDF)

5-fluorouracil, oxaliplatin and dasatinib (FOLFOX-D) for previously untreated metastatic pancreatic adenocarcinoma

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.TPS517-TPS517

2017

Volltextzugriff (PDF)

Clinical Factors as a Component of the Personalized Treatment Approach to Advanced Pancreatic Cancer: a Systematic Literature Review

Journal of gastrointestinal cancer, 2018-03, Vol.49 (1), p.1-8

2018

Volltextzugriff (PDF)

865 Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1121-S-1121

2015

Volltextzugriff (PDF)

862 Pancreaticojejunostomy Stricture After Pancreatoduodenectomy: Outcomes After Operative Revision

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1119-S-1120

2015

Volltextzugriff (PDF)

Cytology from endoscopic retrograde cholangiopancreatography in the evaluation of invasive pancreatic head intraductal papillary mucinous neoplasm: A necessity?

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.266-266

2015

Volltextzugriff (PDF)

Gastric Adenocarcinoma

Shackelford's Surgery of the Alimentary Tract, 2019, p.712-718

Eighth Edition, 2019

Volltextzugriff (PDF)

Laparoscopic Choledochoduodenostomy for the Management of Post Gastric Bypass Biliary Stricture

CSurgeries, 2016-03

2016

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(38)
Buchkapitel
(3)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(20)
Humans
(15)
Female
(11)
Adult
(9)
Male
(9)
Surgery
(9)
Middle Aged
(8)
Gastroenterology & Hepatology
(7)
Retrospective Studies
(7)
Aged
(6)
Medicine
(6)
Medicine & Public Health
(6)
Aged, 80 And Over
(5)
Gastroenterology
(5)
Gastroenterology And Hepatology
(4)
Mortality
(4)
Pancreaticoduodenectomy
(4)
Adolescent
(3)
Carcinoma, Pancreatic Ductal - Pathology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pancreaticojejunostomy Stricture After Pancreatoduodenectomy: Outcomes After Operative Revision

A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma

Analysis of the Cost Effectiveness of Laparoscopic Pancreatoduodenectomy

Intraductal papillary mucinous neoplasm of the pancreas, one manifestation of a more systemic disease?

Invasive, mixed-type intraductal papillary mucinous neoplasm: Superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm

Local blockade of integrins in the temporomandibular joint region reduces Fos-positive neurons in trigeminal subnucleus caudalis of female rats produced by jaw movement

Biliary intervention rates during neoadjuvant therapy for adenocarcinoma of the pancreatic head

Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma

A phase II, open-label pilot study evaluating the safety and activity of Nal-IRI in combination with 5-FU and oxaliplatin in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI Study) (NCT03483038)

Su1403 Surgical Transgastric Necrosectomy for Symptomatic Pancreatic Necrosis in Acute Necrotizing Pancreatitis

412 - A Soluble Protein Signature can Predict Post-Surgical Survival in Pancreatic Adenocarcinoma

Hepatic angiosarcoma five years following spontaneous intraperitoneal bleed of a hepatic mass

A phase II, open-label pilot study evaluating the safety and activity of nal-IRI in combination with 5-FU and oxaliplatin in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI study)

Final toxicity results from a phase II study of 5-fluorouracil, oxaliplatin, and dasatinib (FOLFOX-D) in previously untreated metastatic pancreatic adenocarcinoma

Characteristics of circulating tumor cells in newly diagnosed metastatic pancreatic adenocarcinoma

Circulating tumor cells as a surrogate for treatment response in patients with metastatic pancreatic adenocarcinoma

Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes

Final results from a phase II study of 5-fluorouracil, oxaliplatin, and dasatinib (FOLFOX-D) in previously untreated metastatic pancreatic adenocarcinoma

5-fluorouracil, oxaliplatin and dasatinib (FOLFOX-D) for previously untreated metastatic pancreatic adenocarcinoma

Clinical Factors as a Component of the Personalized Treatment Approach to Advanced Pancreatic Cancer: a Systematic Literature Review

865 Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

862 Pancreaticojejunostomy Stricture After Pancreatoduodenectomy: Outcomes After Operative Revision

Cytology from endoscopic retrograde cholangiopancreatography in the evaluation of invasive pancreatic head intraductal papillary mucinous neoplasm: A necessity?

Gastric Adenocarcinoma

Laparoscopic Choledochoduodenostomy for the Management of Post Gastric Bypass Biliary Stricture

Suchergebnisse filtern